Testing effectiveness (Phase 2)Looking for participantsNCT06364176
What this trial is testing
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Who this might be right for
Cystic Fibrosis
University of Kansas Medical Center 42